ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,548.34
      2.06%
      US Tech 100
      18,866.00
      3.09%
      Dow Jones
      41,182.53
      1.08%
      Brent Oil
      80.985
      3.08%
      Bitcoin
      66,496.81
      0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Elicio Therapeutics Inc (ELTX)

      7. Elicio Therapeutics Inc (ELTX) Financials

      Elicio Therapeutics Inc

      Elicio Therapeutics Inc (ELTX)

      NASDAQ
      4.9718
      -0.0182
      ( -0.36% )
      Updated: 14:31:53
      Delayed by 15 minutes

      Elicio Therapeutics Inc Financial Summary

      The current ELTX market cap is 51.06M. The company's latest EPS is USD -3.4269 and P/E is -1.43.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.61M-10.98M-10.56M-9.39M-10.24M
      Net Income -4.54M-11.05M-10.66M-8.95M-11.83M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.49M2.88M28.31M2.3M0
      Operating Income -38.59M-55.34M-39.31M-39.62M-35.75M
      Net Income -40.66M-80.11M-54.57M-38.81M-35.2M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 41.77M37.62M30.99M27.15M24.48M
      Total Liabilities 2.1M14.06M17.7M15.77M19.61M
      Total Equity 39.67M23.56M13.29M11.37M4.87M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 11.89M47.35M96.51M52.79M27.15M
      Total Liabilities 30.47M137.8M15.01M9.02M15.77M
      Total Equity -18.59M-90.45M81.51M43.77M11.37M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -8.08M-17.61M-22.8M-32.69M-12.12M
      Investing -10M13k-32k-32k3k
      Financing -3.27M31.55M31.61M38.61M11.02M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -24.59M-22.89M-52.64M-38.39M-32.69M
      Investing -242k-41k-382k N/A -32k
      Financing 4.89M52.41M107.17M-60k38.61M

      Stats and Ratios

      Market Cap 51.06M
      Price to Earnings Ratio -1.43
      Price to Sales Ratio 0
      Price to Cash Ratio 3.91
      Price to Book Ratio 4.43
      Dividend Yield -

      Share Statistics

      Shares Outstanding 10.27M
      Average Volume (1 week) 26.55k
      Average Volume (1 Month) 45.48k
      52 Week Change -50.23%
      52 Week High 11.45
      52 Week Low 2.96
      Spread (Intraday) 0.07 (1.39%)

      Company Info

      Company Name Elicio Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.elicio.com
      Industry pharmaceutical preparations (2834)